Europe — EMA
Noradrenaline Viatris (Noradrenaline Tartrate)
GNH USA supplies Noradrenaline Viatris (Noradrenaline Tartrate), a sympathomimetic vasopressor for acute hypotension, septic shock, and cardiac arrest.
Request sourcing
What is Noradrenaline Tartrate?
Noradrenaline Tartrate, the active ingredient in Noradrenaline Viatris, is a sympathomimetic (vasopressor) presented as an injectable solution for intravenous use. It is employed to raise blood pressure in acute hypotensive states such as septic shock, cardiac arrest, and post‑operative hypotension. GNH USA supplies Noradrenaline Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Noradrenaline Tartrate used for?
Noradrenaline acts on the adrenergic system to provide rapid vasoconstriction and cardiac support in critical care settings.
Acute hypotension: restores systemic vascular resistance and improves perfusion pressure. Septic shock: counteracts vasodilatory shock to maintain mean arterial pressure. Cardiac arrest: supports coronary and cerebral perfusion during resuscitation. Post‑operative hypotension: stabilizes blood pressure after surgery.
What are the side effects of Noradrenaline Tartrate?
Noradrenaline may be associated with a range of adverse reactions, varying from mild to severe.
Common Side Effects: - Headache: transient headache due to rapid blood pressure changes. - Tachycardia: increased heart rate from β1 stimulation. - Peripheral ischemia: reduced blood flow to extremities. - Nausea: gastrointestinal discomfort.
Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Severe hypertension: excessive rise in blood pressure. - Tissue necrosis at injection site: local tissue damage if extravasation occurs. - Myocardial ischemia: reduced coronary perfusion causing chest pain.
What precautions apply to Noradrenaline Tartrate?
When using Noradrenaline, careful monitoring and specific safety measures are required.
Dose titration: adjust infusion rate to target blood pressure. Cardiovascular monitoring: continuous ECG and arterial pressure monitoring required. Extravasation risk: avoid infiltration; stop infusion immediately if leakage suspected. Concomitant MAO inhibitors: contraindicated due to risk of hypertensive crisis. Pregnancy and lactation: safety not established; use only if benefits outweigh risks. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Noradrenaline Tartrate interact with?
Noradrenaline can interact with several drug classes, necessitating vigilance.
Major Interactions (Avoid): - MAO inhibitors: can cause severe hypertension. - Tricyclic antidepressants: additive sympathomimetic effect. - β‑blockers: may blunt β1 mediated cardiac response.
Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance vasoconstriction. - Diuretics: may potentiate hypotensive episodes if dose reduced. - Inhaled anesthetics: may alter vascular tone.



